<html>
<head>PUBMED IDs for Kv7.3</head>
<body bgcolor='#C5F0F2'><h1>Kv7.3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17237198/'>Inactivation as a new regulatory mechanism for neuronal Kv7 channels.</a> January 24  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18061539/'>Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs.</a> December 7  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18089837/'>N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator.</a> December 20  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18483067/'>Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization.</a> May 17  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18483052/'>Medicine may change our genes.</a> May 17  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18698150/'>Correlating the clinical and genetic features of benign familial neonatal seizures (BFNS) with the functional consequences of underlying mutations.</a> August 14  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18698135/'>Hyperoxaluria is reduced and nephrocalcinosis prevented with an oxalate-degrading enzyme in mice with hyperoxaluria.</a> August 14  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19298256/'>Neural KCNQ (Kv7) channels.</a> January 6  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19298246/'>Oligoclonal TRBV gene usage among CD8(+) T cells in monoclonal B lymphocytosis and CLL.</a> July 1  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19298244/'>Peroxiredoxin I is overexpressed in oncocytic lesions of salivary glands.</a> October 30  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19298242/'>Differential gene expression profiles of whole lesions from patients with oral lichen planus.</a> September 25  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19559753/'>Functional analysis of novel KCNQ2 mutations found in patients with Benign Familial Neonatal Convulsions.</a> October 8  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20610766/'>A pore residue of the KCNQ3 potassium M-channel subunit controls surface expression.</a> August 17  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20940059/'>Made for &quot;anchorin&quot;: Kv7.2/7.3 (KCNQ2/KCNQ3) channels and the modulation of neuronal excitability in vertebrate axons.</a> July 12  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/24086693/'>Tamoxifen inhibition of kv7.2/kv7.3 channels.</a> July 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25740509/'>Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunits.</a> May 2  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25960349/'>Functional analysis of potassium channels in Kv7.2 G271V mutant causing early onset familial epilepsy.</a> March 5  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26007637/'>A recurrent KCNQ2 pore mutation causing early onset epileptic encephalopathy has a moderate effect on M current but alters subcellular localization of Kv7 channels.</a> March 2  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26820972/'>Generation and characterization of human cardiac resident and non-resident mesenchymal stem cell.</a> January 29  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26910900/'>Retigabine, a Kv7.2/Kv7.3-Channel Opener, Attenuates Drug-Induced Seizures in Knock-In Mice Harboring Kcnq2 Mutations.</a> July 22  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27030113/'>A Kv7.2 mutation associated with early onset epileptic encephalopathy with suppression-burst enhances Kv7/M channel activity.</a> June 1  2016<br></body></html>
